Global Bio-fermented Alanyl-Glutamine Market Strategic Research Report

Scope of the Report

The global Bio-fermented Alanyl-Glutamine market size is predicted to grow from US$ 102 million in 2025 to US$ 158 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.

In 2025, the global sales volume of bio-fermented Alanyl-Glutamine reached 966 metric tons, with an average price of $103.1 per kilogram.

Alanyl-Glutamine (Ala-Gln) is a dipeptide compound formed by linking alanine and glutamine via a peptide bond. As a stable derivative of glutamine, it overcomes the limitations of free glutamine—specifically its low water solubility and poor stability (free glutamine decomposes into glutamic acid or cyclizes into pyrrolidone carboxylic acid under acidic or alkaline conditions and at elevated temperatures). Offering superior water solubility and thermal stability, it serves as a commonly used "conditionally essential amino acid" supplement in clinical nutritional support.

The bio-fermentation method utilizes genetically engineered microorganisms (such as *Corynebacterium glutamicum* or *Escherichia coli*) as "cell factories." Within a fermenter, microbial metabolism converts carbon sources (e.g., glucose) into the target product. Compared to chemical synthesis and enzymatic methods, fermentation offers advantages such as mild reaction conditions, low costs, high product purity, and environmental friendliness, making it the mainstream process for industrial production.

The raw material system for bio-fermented Alanyl-Glutamine comprises four main categories: carbon sources, nitrogen sources, inorganic salts and trace elements, and growth factors. Carbon sources are the most critical raw materials in the fermentation process, primarily derived from the deep processing of agricultural products such as corn, soybeans, and wheat. Glucose is the most commonly used carbon source—typically prepared from corn starch—and the efficiency of its conversion directly impacts final yield and production costs. Additionally, to reduce raw material expenses, some companies are exploring the use of agricultural wastes or by-products—such as corn stover enzymatic hydrolysate, rice bran extract, and molasses—as partial substitutes for traditional carbon sources; these alternatives not only lower costs but also facilitate resource recycling. Nitrogen sources—such as soybean meal, yeast extract, fish bone hydrolysate, corn steep liquor, and ammonium sulfate—provide the essential nitrogen required for microbial growth and amino acid synthesis. Although inorganic salts and trace elements (e.g., potassium dihydrogen phosphate, magnesium sulfate, zinc carbonate, manganese sulfate, copper sulfate, iron sulfate) and growth factors (e.g., vitamin B1, biotin) are used in small quantities, they play a critical regulatory role in microbial metabolism and product synthesis, making them indispensable.

In terms of cost structure, raw materials typically account for 40%–60% of the total cost of amino acid production via fermentation, with carbon sources (glucose) and nitrogen sources representing the largest expenditures. Energy costs (steam and electricity for sterilization, temperature control, agitation, etc.) account for approximately 15%–25%; the fermentation process requires strict maintenance of temperature, pH, and dissolved oxygen levels, resulting in high energy consumption. Equipment depreciation and maintenance costs—including the amortization of investments in fermenters and separation/purification equipment (such as ion-exchange columns and membrane filtration systems)—account for about 10%–15%. Labor and management costs make up roughly 5%–10%. Additionally, downstream extraction and purification costs (e.g., isoelectric point precipitation, ion exchange, flocculation for cell removal, crystallization, and drying) constitute a significant portion of the total cost, as the efficiency of extraction directly impacts the final yield and cost-effectiveness. Overall, the fermentation method offers significant cost advantages over chemical synthesis; it utilizes renewable agricultural products and is environmentally friendly. Furthermore, continuous improvements in strain engineering and process optimization—leading to higher sugar-to-acid conversion rates and extraction yields—will further reduce unit production costs.

This report presents a comprehensive overview of the global Bio-fermented Alanyl-Glutamine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Enzymatic Method
• Fermentation Method

Segment by Grade

• Pharmaceutical Grade
• Food Grade
• Feed Grade

Segment by Strains

• CorynebacteriumGlutamicum
• Escherichia Coli
• Brevibacterium Flavum

Segment by Application

• Pharmaceuticals Industry
• Food & Beverages
• Sports Nutrition & Supplements
• Animal Feed
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Bio-fermented Alanyl-Glutamine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceuticals Industry, Food & Beverages, Sports Nutrition & Supplements evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact